Mario Lozano‐Chiu

2.0k total citations
18 papers, 1.6k citations indexed

About

Mario Lozano‐Chiu is a scholar working on Infectious Diseases, Epidemiology and Cell Biology. According to data from OpenAlex, Mario Lozano‐Chiu has authored 18 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 7 papers in Epidemiology and 4 papers in Cell Biology. Recurrent topics in Mario Lozano‐Chiu's work include Antifungal resistance and susceptibility (14 papers), Fungal Infections and Studies (5 papers) and Plant Pathogens and Fungal Diseases (4 papers). Mario Lozano‐Chiu is often cited by papers focused on Antifungal resistance and susceptibility (14 papers), Fungal Infections and Studies (5 papers) and Plant Pathogens and Fungal Diseases (4 papers). Mario Lozano‐Chiu collaborates with scholars based in United States, Netherlands and Belgium. Mario Lozano‐Chiu's co-authors include John Rex, Victor L. Paetznick, Sevtap Arıkan, Elias Anaissie, H. Vanden Bossche, Françoise Dromer, Dominique Sanglard, Mahmoud A. Ghannoum, Miki Kasai and María Cecilia Dignani and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Mario Lozano‐Chiu

18 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mario Lozano‐Chiu United States 16 1.3k 962 332 221 186 18 1.6k
Sevtap Arıkan Türkiye 19 989 0.8× 745 0.8× 275 0.8× 172 0.8× 173 0.9× 40 1.3k
J. L. Rodriguez-Tudela Spain 18 1.2k 1.0× 942 1.0× 521 1.6× 385 1.7× 216 1.2× 24 1.7k
Adrien Székely United Kingdom 24 1.4k 1.1× 1.1k 1.1× 363 1.1× 198 0.9× 134 0.7× 30 1.8k
L H Hanson United States 23 1.1k 0.9× 972 1.0× 148 0.4× 145 0.7× 224 1.2× 33 1.6k
Caroline B. Moore United Kingdom 28 1.9k 1.5× 1.5k 1.5× 323 1.0× 222 1.0× 373 2.0× 49 2.3k
Teresa M. Dı́az-Guerra Spain 14 904 0.7× 630 0.7× 246 0.7× 241 1.1× 145 0.8× 20 1.1k
Victor L. Paetznick United States 26 1.9k 1.5× 1.5k 1.5× 447 1.3× 257 1.2× 318 1.7× 34 2.4k
A. Fothergill United States 10 799 0.6× 606 0.6× 204 0.6× 136 0.6× 142 0.8× 11 1.1k
M. Cuenca‐Estrella Spain 20 1.6k 1.2× 1.2k 1.3× 512 1.5× 386 1.7× 264 1.4× 28 2.2k
João Nóbrega de Almeida Brazil 24 1.4k 1.1× 1.2k 1.3× 258 0.8× 163 0.7× 147 0.8× 77 1.9k

Countries citing papers authored by Mario Lozano‐Chiu

Since Specialization
Citations

This map shows the geographic impact of Mario Lozano‐Chiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Lozano‐Chiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Lozano‐Chiu more than expected).

Fields of papers citing papers by Mario Lozano‐Chiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mario Lozano‐Chiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Lozano‐Chiu. The network helps show where Mario Lozano‐Chiu may publish in the future.

Co-authorship network of co-authors of Mario Lozano‐Chiu

This figure shows the co-authorship network connecting the top 25 collaborators of Mario Lozano‐Chiu. A scholar is included among the top collaborators of Mario Lozano‐Chiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mario Lozano‐Chiu. Mario Lozano‐Chiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Arıkan, Sevtap, Luis Ostrosky‐Zeichner, Mario Lozano‐Chiu, et al.. (2002). In Vitro Activity of Nystatin Compared with Those of Liposomal Nystatin, Amphotericin B, and Fluconazole against ClinicalCandidaIsolates. Journal of Clinical Microbiology. 40(4). 1406–1412. 42 indexed citations
2.
Arıkan, Sevtap, Mario Lozano‐Chiu, Victor L. Paetznick, & John Rex. (2002). In Vitro Synergy of Caspofungin and Amphotericin B against Aspergillus and Fusarium spp. Antimicrobial Agents and Chemotherapy. 46(1). 245–247. 233 indexed citations
3.
Anaissie, Elias, John Rex, Andrea Francesconi, et al.. (2001). Fusariosis Associated with Pathogenic Fusarium Species Colonization of a Hospital Water System: A New Paradigm for the Epidemiology of Opportunistic Mold Infections. Clinical Infectious Diseases. 33(11). 1871–1878. 235 indexed citations
4.
Arıkan, Sevtap, Mario Lozano‐Chiu, Victor L. Paetznick, & John Rex. (2001). In Vitro Susceptibility Testing Methods for Caspofungin against Aspergillus and Fusarium Isolates. Antimicrobial Agents and Chemotherapy. 45(1). 327–330. 171 indexed citations
5.
Lozano‐Chiu, Mario, et al.. (1999). Disk Diffusion Method for Determining Susceptibilities of Candida spp. to MK-0991. Journal of Clinical Microbiology. 37(5). 1625–1627. 32 indexed citations
6.
Arıkan, Sevtap, et al.. (1999). Microdilution Susceptibility Testing of Amphotericin B, Itraconazole, and Voriconazole against Clinical Isolates of Aspergillus and Fusarium Species. Journal of Clinical Microbiology. 37(12). 3946–3951. 118 indexed citations
7.
Lozano‐Chiu, Mario, S. Arıkan, Victor L. Paetznick, et al.. (1999). Treatment of Murine Fusariosis with SCH 56592. Antimicrobial Agents and Chemotherapy. 43(3). 589–591. 58 indexed citations
8.
Lozano‐Chiu, Mario, S. Arıkan, Victor L. Paetznick, E. Anaissie, & John Rex. (1999). Optimizing Voriconazole Susceptibility Testing of Candida : Effects of Incubation Time, Endpoint Rule, Species of Candida , and Level of Fluconazole Susceptibility. Journal of Clinical Microbiology. 37(9). 2755–2759. 32 indexed citations
9.
Pfaller, Michael A., S. Arıkan, Mario Lozano‐Chiu, et al.. (1998). Clinical Evaluation of the ASTY Colorimetric Microdilution Panel for Antifungal Susceptibility Testing. Journal of Clinical Microbiology. 36(9). 2609–2612. 29 indexed citations
10.
Lozano‐Chiu, Mario, Michael V. Lancaster, & John Rex. (1998). Evaluation of a Colorimetric Method for Detecting Amphotericin B-Resistant Candida Isolates. Diagnostic Microbiology and Infectious Disease. 31(3). 417–424. 9 indexed citations
13.
Bossche, H. Vanden, et al.. (1998). Antifungal drug resistance in pathogenic fungi.. PubMed. 36 Suppl 1. 119–28. 237 indexed citations
14.
Lozano‐Chiu, Mario, Victor L. Paetznick, Mahmoud A. Ghannoum, & John Rex. (1998). Detection of Resistance to Amphotericin B among Cryptococcus neoformans Clinical Isolates: Performances of Three Different Media Assessed by Using E-Test and National Committee for Clinical Laboratory Standards M27-A Methodologies. Journal of Clinical Microbiology. 36(10). 2817–2822. 96 indexed citations
15.
Smith, Nathaniel, Edward A. Graviss, Rayhan Hashmey, et al.. (1997). Multi-drug-resistant cryptococcal meningitis in an AIDS patient. Clinical Infectious Diseases. 25(2). 1 indexed citations
16.
Lozano‐Chiu, Mario, et al.. (1997). Point Prevalence of Oropharyngeal Carriage of Fluconazole‐ResistantCandidain Human Immunodeficiency Virus–Infected Patients. Clinical Infectious Diseases. 25(4). 843–846. 43 indexed citations
18.
Lozano‐Chiu, Mario, et al.. (1997). Lot-to-lot variability of antibiotic medium 3 used for testing susceptibility of Candida isolates to amphotericin B. Journal of Clinical Microbiology. 35(1). 270–272. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026